|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Department of Physiology, and 2Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany
Submitted 16 December 2005 ; accepted in final form 16 May 2006
| ABSTRACT |
|---|
|
|
|---|
annexin V; osmotic cell shrinkage; calcium; apoptosis
Phosphatidylserine-exposing cells, including mature red blood cells, are cleared by macrophages (7, 19, 21, 41). Accordingly, enhanced eryptosis shortens the life span of erythrocytes and thus favors the development of anemia. Phosphatidylserine-exposing erythrocytes could further adhere to the vascular wall and thus interfere with microcirculation (8, 13, 19, 22, 37, 44, 45). Because of the delicate balance between hematopoiesis and red blood cell removal, suicidal death of circulating erythrocytes is supposed to be a tightly regulated mechanism (9, 16, 28, 40).
The susceptibility to eryptosis may be influenced by the type of expressed hemoglobin. For instance, erythrocytes from patients with sickle cell anemia and thalassemia are more sensitive to apoptotic stimuli (32), a property correlating with the shortened erythrocyte life span in those disorders (5, 14, 42, 46). Fetal erythrocytes mainly contain fetal hemoglobin (20) and have been shown to differ from adult erythrocytes in their K+ transport properties (23). On the other hand, K+ exit from the cells is not only necessary for eryptotic shrinkage but also favors Ca2+-induced phosphatidylserine exposure at the erythrocyte membrane (33). The present study has thus been performed to explore the sensitivity of neonatal erythrocytes to different stimuli of eryptosis. To this end, neonatal erythrocytes have been compared with erythrocytes from adult volunteers, and their cation channel activities, their intracellular Ca2+ concentrations, phosphatidylserine exposure after different stressors, and their ability to generate prostaglandin E2 (PGE2) after Cl removal have been determined.
| METHODS |
|---|
|
|
|---|
Patch-clamp experiments.
Patch pipettes made of borosilicate glass (model 150 TF-10; Clark Medical Instruments, Pangbourne, UK) were pulled using a horizontal DMZ puller (Zeitz, Augsburg, Germany). Pipettes with high resistance from 8 to 12 M
were connected via an Ag-AgCl wire to the headstage of a patch-clamp amplifier (model EPC 9; HEKA, Lambrecht, Germany). Data acquisition and analysis were controlled by a computer equipped with an ITC 16 interface (Instrutech, Port Washington, NY) and with the use of Pulse software (HEKA), as described earlier (18). For current measurements (room temperature), red blood cells were held at a holding potential of 20 to 30 mV and 200- or 400-ms pulses from 100 to +80 mV were applied in increments of +20 mV. The original whole cell current traces are depicted without filtering (acquisition frequency of 5 kHz). The currents were analyzed by averaging the current values measured between 350 and 375 ms of each square pulse current-voltage (I-V relationship). The applied voltages refer to the cytoplasmic face of the membrane with respect to the extracellular space. The offset potentials between both electrodes were zeroed before sealing. The liquid junction potentials between the bath and pipette solutions and between the bath solutions and the salt bridge (filled with NaCl bath solution) were calculated according to Barry and Lynch (3). Data were corrected for liquid junction potentials.
The pipette solution contained (in mM) 115 Na gluconate, 10 NaCl, 1 MgATP, 1 EGTA, and 5 HEPES/NaOH (pH 7.4). In the bath, NaCl and Cl-free Ringer solutions (see above) were used.
Measurement of intracellular Ca2+. Intracellular Ca2+ measurements were performed as described (2). Briefly, erythrocytes were loaded with fluo-3 AM (Calbiochem, Bad Soden, Germany) by addition of 2 µl of a fluo-3 AM stock solution (2 mM in DMSO) to 1 ml erythrocyte suspension (3% hematocrit in NaCl Ringer solution). The cells were incubated at 37°C for 15 min. An additional 2-µl aliquot of fluo-3 AM was added, with incubation carried out for 25 min. Fluo-3-loaded erythrocytes were centrifuged at 1,000 g for 5 min at 22°C and washed two times with NaCl Ringer solution containing 1% bovine serum albumin (Sigma) and one time with albumin-free Ringer solution. For flow cytometry, fluo-3-loaded erythrocytes were resuspended in 1 ml of Ringer solution (3% hematocrit), or Cl-free Ringer solution either in the presence or absence of the Ca2+ ionophore ionomycin (1 µM; Sigma) or vehicle alone. Cells were incubated for 5 min (ionomycin-treated cells that were used as a fluo-3 loading control, data not shown) or 6 h at 37°C. Ca2+-dependent fluorescence intensity of 20,000 cells was then measured by flow cytometric analysis on a fluorescence-activated cell sorter (FACS-Calibur; Becton Dickinson, Heidelberg, Germany) in the fluorescence channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.
FACS analysis. FACS analysis was performed as described in detail elsewhere (1, 30). After incubation in the respective solutions, cells were washed in annexin-binding buffer containing (in mM) 125 NaCl, 10 HEPES/NaOH (pH 7.4), and 5 CaCl2. Erythrocytes were stained with Annexin-V-Fluos (Roche Diagnostics, Mannheim, Germany) at a 1:100 dilution. After 15 min, samples were diluted 1 to 5 and measured by flow cytometric analysis. Cells (20,000) were analyzed by forward scatter, and the annexin V fluorescence intensity of those cells was measured in FL-1.
Microscopy. Erythrocytes were exposed for 24 h to Ringer solution or Cl-free Ringer solution (Cl replaced by gluconate) and subsequently placed on polylysine-coated cover slips. Cells were analyzed under a fluorescence microscope with 440/480-nm excitation and 535/550-nm emission wavelength [Q505LP beam splitter; AHF Analysentechnik (Tübingen, Germany)] combined with a Nikon microscope (Düsseldorf, Germany), and digital pictures were taken using a digital imaging system (Visitron Systems, Puchheim, Germany) equipped with Metaview software.
Determination of PGE2 in the supernatant. One billion erythrocytes were exposed to Cl-free Ringer solution (Cl replaced by gluconate) for the indicated time periods. After incubation, the cells were pelleted by centrifugation at 4°C, 450 g for 5 min. The supernatant was removed and stored at 20°C. PGE2 concentrations in the supernatant were determined using the Correlate-EIA Prostaglandin E2 Enzyme Immunoassay Kit (Assay Designs, Ann Arbor, MI) according to the manufacturer's instructions as described elsewhere (34). Briefly, the samples were diluted 1:2.5 with assay buffer, and 100 µl of diluted sample, 50 µl of alkaline phosphatase PGE2 conjugate, and 50 µl of monoclonal anti-PGE2 EIA antibody were then applied to goat anti-mouse IgG microtiter plates and incubated at room temperature for 2 h. After being washed, 200 µl of p-nitrophenyl phosphate substrate solution was added, incubated at room temperature for 45 min, and the optical density at 405 nm was measured in a microplate reader. PGE2 concentrations in the samples were calculated from a PGE2 standard curve, which was run in parallel.
Statistics. Data are expressed as arithmetic means ± SE, and statistical analysis was made by paired or unpaired two-tailed t-test or ANOVA, where appropriate. Differences in means were considered statistically significant if P < 0.05. The number of experiments was adjusted to the variable scatter of the data for each experimental procedure.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
700 mosM) was followed by a marked increase of the percentage of annexin V-binding erythrocytes. The increase was paralleled by a sharp decrease in forward scatter, reflecting erythrocyte shrinkage (Fig. 6, A and B). The effect of hyperosmotic shock on phosphatidylserine exposure was again significantly blunted (Fig. 5, A and B) and the forward scatter was significantly higher in neonatal erythrocytes (Fig. 6, A and B).
|
|
|
40% of the neonatal erythrocytes (Fig. 8B).
|
| DISCUSSION |
|---|
|
|
|---|
The present paper demonstrates the relative insensitivity of neonatal erythrocytes to stimulation of eryptosis by Cl removal or osmotic shock. The relative resistance of neonatal erythrocytes to the eryptotic effects of Cl removal is at least partially due to lacking release of PGE2, which accounts for the activation of the cation channels following Cl removal or osmotic shock (34). Notably, the seemingly complete lack of PGE2 formation does not lead to complete suppression of cation channel activity and eryptosis. Thus additional mechanisms may be involved in the triggering of channel activity and eryptosis of neonatal erythrocytes. Neonatal erythrocytes are further resistant to PAF, which in adult erythrocytes activates a sphingomyelinase (35) with subsequent ceramide formation and ceramide-induced scrambling of the cell membrane (30).
The relative resistance to different eryptotic stimuli counteracts premature death and clearance of neonatal erythrocytes. As shown most recently (25), phosphatidylserine-exposing erythrocytes are cleared in <1 h from circulating blood. However, eryptosis shares similarities with but may be distinct from erythrocyte senescence (4, 9, 28, 40, 43). Thus the life span of erythrocytes is not only determined by eryptosis but by additional mechanisms as well.
In contrast to cation channel-dependent eryptosis following Cl removal or osmotic shock, spontaneous eryptosis appears to be slightly but significantly more rapid in neonatal than in adult erythrocytes. This observation points to additional differences between neonatal and adult erythrocytes, which may be relevant for intrauterine or extrauterine survival of neonatal or adult erythrocytes. Oxidative stress has previously been shown to be a major cause of erythrocyte injury (4, 10, 36, 38). Accordingly, the decreased cation channel activity in neonatal erythrocytes does not necessarily imply that their life span is enhanced, irrespective of their microenvironment. Instead, they may be less resistant to other mechanisms of erythrocyte clearance from circulating blood. The present observations indeed reveal that neonatal erythrocytes are more sensitive to oxidative stress. The exquisite sensitivity to oxidative stress may account for the rapid clearance of neonatal erythrocytes after birth, when the neonatal erythrocytes are exposed to alveolar oxygen.
In conclusion, erythrocytes from neonatal blood express less cation channel activity and are less sensitive to Cl removal or osmotic shock than erythrocytes from adults. In contrast, the neonatal erythrocytes are more sensitive to oxidative stress. The altered sensitivity of neonatal erythrocytes to different eryptotic stimuli may thus contribute to the intrauterine survival and postnatal clearance of neonatal erythrocytes.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Andrews DA, Yang L, and Low PS. Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. Blood 100: 33923399, 2002.
3. Barry PH and Lynch JW. Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 121: 101117, 1991.[CrossRef][Web of Science][Medline]
4. Barvitenko NN, Adragna NC, and Weber RE. Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 15: 118, 2005.[Web of Science][Medline]
5. Benjamin LJ and Manning JM. Enhanced survival of sickle erythrocytes upon treatment with glyceraldehyde. Blood 67: 544546, 1986.
6. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, and Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 8: 11971206, 2001.[CrossRef][Web of Science][Medline]
7. Boas FE, Forman L, and Beutler E. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci USA 95: 30773081, 1998.
8. Bonomini M, Sirolli V, Gizzi F, Di Stante S, Grilli A, and Felaco M. Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure. Kidney Int 62: 13581363, 2002.[CrossRef][Web of Science][Medline]
9. Bosman GJ, Willekens FL, and Werre JM. Erythrocyte aging: a more than superficial resemblance to apoptosis? Cell Physiol Biochem 16: 18, 2005.[CrossRef][Web of Science][Medline]
10. Bracci R, Perrone S, and Buonocore G. Oxidant injury in neonatal erythrocytes during the perinatal period. Acta Paediatr Suppl 91: 130134, 2002.[CrossRef][Medline]
11. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, and Lang F. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 13: 347356, 2003.[CrossRef][Web of Science][Medline]
12. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, and Ameisen JC. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 8: 11431156, 2001.[CrossRef][Web of Science][Medline]
13. Closse C, Dachary-Prigent J, and Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 107: 300302, 1999.[CrossRef][Web of Science][Medline]
14. Corash L, Spielberg S, Bartsocas C, Boxer L, Steinherz R, Sheetz M, Egan M, Schlessleman J, and Schulman JD. Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 303: 416420, 1980.[Abstract]
15. Damonte G, Guida L, Sdraffa A, Benatti U, Melloni E, Forteleoni G, Meloni T, Carafoli E, and De Flora A. Mechanisms of perturbation of erythrocyte calcium homeostasis in favism. Cell Calcium 13: 649658, 1992.[CrossRef][Web of Science][Medline]
16. Daugas E, Cande C, and Kroemer G. Erythrocytes: death of a mummy. Cell Death Differ 8: 11311133, 2001.[CrossRef][Web of Science][Medline]
17. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C, and Lang F. Electrophysiological properties of the Plasmodium falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 13: 189198, 2003.[CrossRef][Web of Science][Medline]
18. Duranton C, Huber SM, and Lang F. Oxidation induces a Cl-dependent cation conductance in human red blood cells. J Physiol 539: 847855, 2002.
19. Eda S and Sherman IW. Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem 12: 373384, 2002.[CrossRef][Web of Science][Medline]
20. Egberts J and Van Pelt J. Evaluation of the blood analyzer ABL 735 radiometer for determination of the percentage of fetal hemoglobin in fetal and neonatal blood. Scand J Clin Lab Invest 64: 128131, 2004.[CrossRef][Web of Science][Medline]
21. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, and Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 8590, 2000.[CrossRef][Medline]
22. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, and Low PS. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 101: 46254627, 2003.
23. Gibson JS, Speake PF, Muzyamba MC, Husain F, Luckas MC, and Ellory JC. K+ transport in red blood cells from human umbilical cord. Biochim Biophys Acta 1512: 231238, 2001.[Medline]
24. Huber SM, Gamper N, and Lang F. Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts. Pflügers Arch 441: 551558, 2001.[CrossRef][Web of Science][Medline]
25. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, and Lang F. Enhanced programmed cell death of iron deficient erythrocytes. FASEB J 20: 368370, 2006.
26. Kiefer CR and Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol 7: 113116, 2000.[CrossRef][Web of Science][Medline]
27. Lang F, Gulbins E, Szabo I, Lepple-Wienhues A, Huber SM, Duranton C, Lang KS, Lang PA, and Wieder T. Cell volume and the regulation of apoptotic cell death. J Mol Recognit 17: 473480, 2004.[CrossRef][Web of Science][Medline]
28. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, and Lang F. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 15: 195202, 2005.[CrossRef][Web of Science][Medline]
29. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, and Huber SM. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 10: 249256, 2003.[CrossRef][Web of Science][Medline]
30. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, and Wieder T. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 11: 231243, 2004.[CrossRef][Web of Science][Medline]
31. Lang KS, Myssina S, Tanneur V, Wieder T, Huber SM, Lang F, and Duranton C. Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 367: 391396, 2003.[CrossRef][Web of Science][Medline]
32. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, and Wieder T. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 12: 365372, 2002.[CrossRef][Web of Science][Medline]
33. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, and Huber SM. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 285: C1553C1560, 2003.
34. Lang PA, Kempe DS, Myssina S, Tanneur V, Birka C, Laufer S, Lang F, Wieder T, and Huber SM. PGE2 in the regulation of programmed erythrocyte death. Cell Death Differ 12: 415428, 2005.[CrossRef][Web of Science][Medline]
35. Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, and Wieder T. Stimulation of erythrocyte ceramide formation by platelet-activating factor. J Cell Sci 118: 12331243, 2005.
36. Mandal D, Moitra PK, Saha S, and Basu J. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 513: 184188, 2002.[CrossRef][Web of Science][Medline]
37. Manodori AB, Barabino GA, Lubin BH, and Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 95: 12931300, 2000.
38. Mavelli I, Ciriolo MR, Rossi L, Meloni T, Forteleoni G, De Flora A, Benatti U, Morelli A, and Rotilio G. Favism: a hemolytic disease associated with increased superoxide dismutase and decreased glutathione peroxidase activities in red blood cells. Eur J Biochem 139: 1318, 1984.[Web of Science][Medline]
39. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, and Lang F. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 14: 27502757, 2003.
40. Rice L and Alfrey CP. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 15: 245250, 2005.[CrossRef][Web of Science][Medline]
41. Romero PJ and Romero EA. Effect of cell ageing on Ca2+ influx into human red cells. Cell Calcium 26: 131137, 1999.[CrossRef][Web of Science][Medline]
42. Ruymann FB, Popejoy LA, and Brouillard RB. Splenic sequestration and ineffective erythropoiesis in hemoglobin E-beta-thalassemia disease. Pediatr Res 12: 10201023, 1978.[Web of Science][Medline]
43. Schwarzer E, Kühn H, Valente E, and Arese P. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 16: 133146, 2005.[CrossRef][Web of Science][Medline]
44. Setty BN, Kulkarni S, and Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 99: 15641571, 2002.
45. Wali RK, Jaffe S, Kumar D, and Kalra VK. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus. Diabetes 37: 104111, 1988.[Abstract]
46. Yang XY, Qu Q, Yang TY, Chan WC, Chu JX, Chen Z, Ning AL, Liu FJ, Lin ZX, and Zhou YL. Treatment of the thalassemia syndrome with splenectomy. Hemoglobin 12: 601608, 1988.[Web of Science][Medline]
47. Zhou Q, Zhao J, Wiedmer T, and Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99: 40304038, 2002.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |